Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy.
about
Empiric antibiotics for community-acquired pneumonia: A macrolide and a beta-lactam please!Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia.Appropriate antibiotic management of bacterial lower respiratory tract infectionsValidation of the prediction rules identifying drug-resistant pathogens in community-onset pneumonia
P2860
Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Mortality in patients with com ...... macrolide combination therapy.
@en
Mortality in patients with com ...... macrolide combination therapy.
@nl
type
label
Mortality in patients with com ...... macrolide combination therapy.
@en
Mortality in patients with com ...... macrolide combination therapy.
@nl
prefLabel
Mortality in patients with com ...... macrolide combination therapy.
@en
Mortality in patients with com ...... macrolide combination therapy.
@nl
P2093
P2860
P50
P356
P1433
P1476
Mortality in patients with com ...... macrolide combination therapy.
@en
P2093
Central Japan Lung Study Group
Hideo Saka
Masahiro Sano
Shigeyuki Matsui
Tetsuya Yagi
Yasuteru Sugino
Yoshinori Hasegawa
P2860
P304
P356
10.1111/RESP.13232
P577
2017-12-14T00:00:00Z